Clinical Trial Update: A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

The document reports the completion status of a Phase II study evaluating Hepalatide in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepalatide

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED